| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
3,765 |
3,646 |
$229K |
| 87637 |
Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV |
1,270 |
1,248 |
$212K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
1,401 |
1,401 |
$157K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
1,756 |
1,723 |
$151K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
1,969 |
1,968 |
$148K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
2,247 |
2,205 |
$61K |
| 99051 |
|
6,416 |
6,249 |
$45K |
| 76140 |
|
1,124 |
1,074 |
$14K |
| 71046 |
Radiologic examination, chest; 2 views |
408 |
402 |
$10K |
| 99050 |
|
281 |
273 |
$6K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
25 |
25 |
$493.19 |
| S9088 |
Services provided in an urgent care center (list in addition to code for service) |
747 |
735 |
$52.33 |
| J8540 |
Dexamethasone, oral, 0.25 mg |
12 |
12 |
$25.22 |
| J7620 |
Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme |
13 |
13 |
$4.08 |